- Q1 2024 Blueprint Medicines Corp Earnings Call TranscriptMay 02, 2024€99.64 (+15.59%)Earnings
- Q4 2023 Blueprint Medicines Corp Earnings Call TranscriptFeb 15, 2024€68 (-1.45%)Earnings
- Blueprint Medicines Corp at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Q3 2023 Blueprint Medicines Corp Earnings Call TranscriptOct 26, 2023€41.4 (-4.61%)Earnings
- Blueprint Medicines Corp at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Q2 2023 Blueprint Medicines Corp Earnings Call TranscriptAug 02, 2023€52 (-12.61%)Earnings
- Blueprint Medicines Corp at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Blueprint Medicines Corp To Discuss The FDA Approval of AYVAKIT in ISM Call TranscriptMay 22, 2023
- Q1 2023 Blueprint Medicines Corp Earnings Call TranscriptMay 04, 2023€46.2 (+1.32%)Earnings
- Blueprint Medicines Corp at Stifel Targeted Oncology Days (Virtual) TranscriptApr 25, 2023
- Blueprint Medicines Corp at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Blueprint Medicines Corp To Discuss The Registrational PIONEER Trial Data Of AYVAKIT In Indolent SM Call TranscriptFeb 27, 2023
- Q4 2022 Blueprint Medicines Corp Earnings Call TranscriptFeb 16, 2023€41.68 (+1.29%)Earnings
- Blueprint Medicines Corp at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Q3 2022 Blueprint Medicines Corp Earnings Call & Investor Day TranscriptNov 01, 2022€51.3 (+0.98%)Earnings
- Blueprint Medicines Corporate call TranscriptAug 17, 2022
- Q2 2022 Blueprint Medicines Corp Earnings Call TranscriptAug 02, 2022€48.32 (-2.01%)Earnings
- Blueprint Medicines Corp Collaborations with Sixth Street and Royalty Pharma - Corporate Call TranscriptJun 30, 2022
- Blueprint Medicines Corp at JMP Securities Life Sciences Conference (Virtual) TranscriptJun 16, 2022
- Blueprint Medicines Corp at Goldman Sachs Global Healthcare Conference TranscriptJun 16, 2022
- Q1 2022 Blueprint Medicines Corp Earnings Call TranscriptMay 03, 2022€55.72 (+2.35%)Earnings
- Blueprint Medicines Corp Call to Discuss Data Reported at AACR TranscriptApr 08, 2022
- Blueprint Medicines Corp at Cowen Health Care Conference (Virtual) TranscriptMar 08, 2022
- Q4 2021 Blueprint Medicines Corp Earnings Call TranscriptFeb 16, 2022€67.56 (-8.13%)Earnings
- Blueprint Medicines Corp to Expand Precision Therapy Leadership in Lung Cancer with Acquisition of Lengo Therapeutics Inc Call TranscriptNov 29, 2021
- Q3 2021 Blueprint Medicines Corp Earnings Call TranscriptOct 28, 2021€88.14 (+0.59%)Earnings
- Blueprint Medicines Corp at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 09, 2021
- Q2 2021 Blueprint Medicines Corp Earnings Call TranscriptJul 29, 2021€69.52 (-0.23%)Earnings
- Blueprint Medicines Corp Corporate Call to Discuss the FDA Approval of AYVAKIT in Advanced SM TranscriptJun 16, 2021
- Blueprint Medicines Corp at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- Blueprint Medicines Corp Annual Shareholders Meeting TranscriptJun 02, 2021
- Q1 2021 Blueprint Medicines Corp Earnings Call TranscriptApr 29, 2021€81.98 (+0.89%)Earnings
- Blueprint Medicines Corp AACR Conference Call TranscriptApr 12, 2021
- Blueprint Medicines Corp at Barclays Global Healthcare Conference (Virtual) TranscriptMar 10, 2021
- Q4 2020 Blueprint Medicines Corp Earnings Call TranscriptFeb 17, 2021€78.76 (+0.90%)Earnings
- Q3 2020 Blueprint Medicines Corp Earnings Call TranscriptOct 29, 2020€88.08 (+0.89%)Earnings
- Blueprint Medicines Corp Advanced Systemic Mastocytosis Topline Data Call TranscriptSep 22, 2020
- Blueprint Medicines Corp at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Blueprint Medicines Corp to Discuss the FDA Approval of GAVRETO Conference Call TranscriptSep 08, 2020
- Q2 2020 Blueprint Medicines Corp Earnings Call TranscriptJul 30, 2020€61.82 (-2.40%)Earnings
- Blueprint Medicines Corp to Discuss the Global Collaboration with Roche to Develop and Commercialize Pralsetinib for Patients with RET-Altered Cancers Call TranscriptJul 14, 2020
- Blueprint Medicines Corp Annual Shareholders Meeting TranscriptJun 23, 2020
- Blueprint Medicines Corp at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2020
- Blueprint Medicines Corp ASCO20 Conference Call TranscriptMay 29, 2020
- Q1 2020 Blueprint Medicines Corp Earnings Call TranscriptMay 06, 2020€54.42 (+3.74%)Earnings
- Blueprint Medicines Corp VOYAGER Corporate Call TranscriptApr 28, 2020
- Blueprint Medicines Corp AAAAI Call TranscriptMar 16, 2020
- Q4 2019 Blueprint Medicines Corp Earnings Call TranscriptFeb 13, 2020€58.5 (+0.86%)Earnings
- Blueprint Medicines Corp AYVAKITâ„¢ FDA Approval Conference Call TranscriptJan 09, 2020
- Blueprint Medicines Corp to Host Investor Event and Webcast to Review Initial Data from the PIONEER Trial Presented at ASH TranscriptDec 09, 2019
- Blueprint Medicines Corp Research and Development Day with Q3 2019 Blueprint Medicines Corp Earnings Call TranscriptNov 05, 2019€60.5 (-0.82%)Earnings
- Blueprint Medicines Corp at Morgan Stanley Healthcare Conference TranscriptSep 10, 2019
- Q2 2019 Blueprint Medicines Corp Earnings Call TranscriptAug 01, 2019€85 (-2.60%)Earnings
- Blueprint Medicines Corp Presents Updated EXPLORER Trial Data for Avapritinib in Patients with Systemic Mastocytosis at 24th EHA Congress TranscriptJun 17, 2019
- Blueprint Medicines Corp at Goldman Sachs Global Healthcare Conference TranscriptJun 12, 2019
- Blueprint Medicines Corp ASCO 2019 Analyst and Investor Reception TranscriptJun 03, 2019
- Blueprint Medicines Corp at Bank of America Merrill Lynch Health Care Conference TranscriptMay 15, 2019
- Q1 2019 Blueprint Medicines Corp Earnings Call TranscriptMay 09, 2019€72.5 (+6.90%)Earnings
- Blueprint Medicines Corp at Cowen Health Care Conference TranscriptMar 12, 2019
- Q4 2018 Blueprint Medicines Corp Earnings Call TranscriptFeb 26, 2019€68.38 (+0.22%)Earnings
Blueprint Medicines Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Hello, and good afternoon. Welcome, again, to the 19th Annual Morgan Stanley Healthcare Conference. Before I get going, let me just go through the requisite disclosures. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
And with that, let me introduce myself. I'm Dave Lebowitz, one of the biotechnology analysts here. I have with me in the next session from Blueprint Medicines COO, Kate Haviland; and President of Research and Development, Fouad Namouni.
Questions & Answers
I guess if you could start maybe to give a top line description of the company, what has happened? There's certainly been an evolution in the last couple of years, a lot of changes and where you're
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)